Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer
Medical Oncology · 2024
DOI: 10.1007/s12032-024-02431-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Mahdieh Ahmadi Kamalabadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Papillomavirus Infections, Gadolinium, Magnetic Resonance Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
In this study, we developed new gadolinium-graphene quantum dot nanoparticles (Gd-GQDs) as a theranostic platform for magnetic resonance imaging and improved the efficiency of radiotherapy in HPV-positive oropharyngeal cancer. Based on cell toxicity results, Gd-GQD NPs were nontoxic for both cancer and normal cell lines up to 25 µg/ml. These NPs enhance the cytotoxic effect of radiation only on cancer cells but not on normal cells. The flow cytometry analysis indicated that cell death mainly occurred in the late phase of apoptosis. The immunocytochemical analysis was used to evaluate apoptosis pathway proteins. The Bcl-2 and p53 protein levels did not differ statistically significantly between radiation alone group and those that received irradiation in combination with NPs. In contrast, the combination group exhibited a significant increase in Bax protein expression, suggesting that cells could undergo apoptosis independent of the p53 pathway. Magnetic resonance (MR) imaging showed that Gd-GQD NPs, when used at low concentrations, enhanced T1-weighted signal intensity resulting from T1 shortening effects. At higher concentrations, the T2 shortening effect became predominant and was able to decrease the signal intensity. Gd-GQD appears to offer a novel approach for enhancing the effectiveness of radiation treatment and facilitating MR imaging for monitoring HPV-positive tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
- Department of Radiology, Faculty of Allied Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
- Department of Pediatrics, Faculty of Medicine, Non-Communicable Disease Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
- Department of Radiology Technology, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Darband St, Ghods Sq., Tehran, 1971653313, Iran. f.koosha@sbmu.ac.ir.
- Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Förderung
- Shahid Beheshti University of Medical Sciences
Zitieren
APA
Ahmadi Kamalabadi, M., Ostadebrahimi, H., Koosha, F., Fatemidokht, A., Menbari Oskuie, I., Amin, F., & Shiralizadeh Dezfuli, A. (2024). Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer. Medical Oncology. https://doi.org/10.1007/s12032-024-02431-4
Vancouver
Ahmadi Kamalabadi M, Ostadebrahimi H, Koosha F, Fatemidokht A, Menbari Oskuie I, Amin F, et al. Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer. Medical Oncology. 2024. doi:10.1007/s12032-024-02431-4
BibTeX
@article{AhmadiKamalabadi2024,
author = {Ahmadi Kamalabadi, Mahdieh and Ostadebrahimi, Hamid and Koosha, Fereshteh and Fatemidokht, Asieh and Menbari Oskuie, Iman and Amin, Fatemeh and Shiralizadeh Dezfuli, Amin},
title = {Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer},
journal = {Medical Oncology},
year = {2024},
doi = {10.1007/s12032-024-02431-4}
}
EUVIMED